Short answer
Medtronic (MDT) filed an 8-K current report with the SEC on May 18, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Brett Wall departing EVP and President, Neuroscience Portfolio, effective June 1, 2026.
Medtronic 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Brett Wall departing EVP and President, Neuroscience Portfolio, effective June 1, 2026
- Dr. Kweli Thompson succeeding Wall; currently leads Cardiac Rhythm Management
- Wall remaining with Medtronic through September 1, 2026 for transition support
- Severance payments and benefits under executive-officer practices disclosed in the 2025 Proxy Statement
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Medtronic 8-K filings
Get the next MDT 8-K as it lands
Follow MDT for push alerts, or ask the research agent what this filing means.